This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ucb Pharma Gmbh. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Mahmoud Rashed: Innovator in GPR17 Modulation
Introduction
Mahmoud Rashed is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target GPR17-associated disorders. His innovative work has the potential to impact various therapeutic areas.
Latest Patents
Mahmoud Rashed holds a patent for "Pyridinyl and pyrazinyl-(asa)indolsulfonamides." This invention relates to pyridinyl and pyrazinyl-(aza)indolsulfonamides that exhibit GPR17 modulator activity. The compounds developed by Rashed are designed to be useful in treating a variety of disorders associated with GPR17. He has 1 patent to his name.
Career Highlights
Rashed is currently employed at UCB Pharma GmbH, where he continues to advance his research and development efforts. His work at UCB Pharma has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Laurent Provins and Ali El-Tayeb. Their combined expertise contributes to the innovative environment at UCB Pharma.
Conclusion
Mahmoud Rashed is a dedicated inventor whose work in GPR17 modulation holds promise for the treatment of various disorders. His contributions to the pharmaceutical industry exemplify the impact of innovation in healthcare.